FY15
Assets145.84
Net Worth37.57
Total Debt59.63
RevenueAnnualised basis218.30
EBITDAAnnualised basis28.75
PATAnnualised basis7.51
EBITDA Margin (%)13.17
At a glance
Updated 2026-09-04Bajaj Healthcare is an IPO with an issue size of ₹30.90 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹30.90 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets160.69₹ Cr · +22.7% vs prior year
Net Worth43.76₹ Cr · +55.8% vs prior year
FY14
Assets145.42
Net Worth30.05
Total Debt63.10
RevenueAnnualised basis204.90
EBITDAAnnualised basis19.41
PATAnnualised basis1.97
EBITDA Margin (%)9.47
FY13
Assets131.00
Net Worth28.08
Total Debt63.64
RevenueAnnualised basis170.77
EBITDAAnnualised basis12.89
PATAnnualised basis-1.05
EBITDA Margin (%)7.55
31-Dec-15
Assets160.69
Net Worth43.76
Total Debt72.69
RevenueAnnualised basis172.49
EBITDAAnnualised basis21.56
PATAnnualised basis6.45
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Bajaj Healthcare IPO | — | 14.00 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-04.
IPO UPDATE ALERTS
Register for IPO Updates →Track Bajaj Healthcare without missing an update
Register for subscription, GMP, allotment and listing notifications.